Latest news with #PrathapReddy
Time of India
30-06-2025
- Business
- Time of India
Apollo Hospitals to hive off pharmacy, digital biz
Chennai: Apollo Hospitals Enterprise, controlled by the Prathap Reddy family, has announced a significant reorganisation where its pharmacy distribution and digital health operations will be carved out into a separate entity. This new entity, Apollo Healthtech, will seek listing on stock exchanges over the next 18 to 21 months, with current Apollo Hospitals shareholders receiving proportionate shares in the new company. The deal will create a leading omni-channel pharmacy distribution and digital health platform in India with revenues of Rs 16,300 crore ($1.9 billion), Apollo Hospitals said in a statement. Currently, Apollo Healthco (AHL) manages the wholesale pharmaceutical trading and Apollo 24/7 digital platform, while Keimed oversees wholesale distribution of pharmaceuticals and wellness products. Apollo Hospitals holds about 79% ownership in AHL, and Keimed operates as a related party to Apollo Hospitals. You Can Also Check: Chennai AQI | Weather in Chennai | Bank Holidays in Chennai | Public Holidays in Chennai The share allocation structure stipulates that for every 100 shares held in Apollo Hospitals, shareholders will receive 195.2 shares in the new company. AHL shareholders will get 89.5 shares for every 100 shares owned, while Keimed shareholders will receive 3045.2 shares for every 100 shares held. Following the completion of this demerger, both AHL and Keimed will cease to exist. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Cardiologists: 1 Teaspoon of This Before Bed Melts Belly Fat Like Crazy Hollywood News | USA Click Here Undo Under the agreement terms, Apollo Hospitals shall restrict its pharmaceutical operations exclusively to hospital-based pharmacies, refraining from any involvement in e-commerce, retail or wholesale pharmacy ventures. Veda Corporate Advisors was the exclusive financial advisor to the transaction. The new company, Apollo Healthtech, will subsequently acquire 74.5% stake in Apollo Medicals, consolidating the front-end pharmacy business. Apollo Hospitals will own a 15% stake in Apollo Healthtech and will have one nominee director on the board, the Chennai-based company said. Apollo Hospitals chairman Prathap C Reddy, said: "Today's developments mark the beginning of the next chapter of Apollo Hospitals. The omnichannel pharmacy business and integrated digital healthcare ecosystem will be a unique model to enable access to high-quality healthcare for millions of Indians."
&w=3840&q=100)
Business Standard
02-06-2025
- Business
- Business Standard
Why were Apollo Hospitals shares buzzing in a weak market? Find out here
Apollo Hospitals share price: Healthcare company Apollo Hospitals share price rose as much as 3.07 per cent to hit an intraday high of 7,090 per share on Monday, June 2, 2025. However, at 1:08 PM, Apollo Hospitals shares were off day's highs, and were trading 1.19 per cent higher at 6,959.95 apiece. In comparison, BSE Sensex was trading 0.22 per cent lower at 81,269.01 levels. Why did Apollo Hospitals shares rise in trade today? Apollo Hospitals Enterprise shares rose on the back of strong performance for the quarter ended March 31, 2025 (Q4FY25), with a year-on-year (Y-o-Y) growth across key financial indicators. The company posted a consolidated profit after tax (PAT) of ₹389.7 crore, marking a 54 per cent increase from ₹253.8 crore in Q4FY24. The revenue for the quarter came in at ₹5,592.3 crore, reflecting a 13 per cent Y-o-Y rise from ₹4,943.9 crore in the same period last year. At the operating level, earnings before interest, tax, depreciation, and amortisation (Ebitda) stood at ₹769.9 crore in Q4FY25, registering a 20 per cent growth compared to ₹640.5 crore in Q4FY24. The Ebitda figure includes costs related to Apollo 24/7 amounting to ₹160.3 crore during the quarter, which also factors in a non-cash employee stock option (ESOP) charge of ₹45.5 crore. This compares to Apollo 24/7 costs of ₹150.8 crore in the corresponding quarter of the previous year. Apollo Hospitals dividend The Board of Directors has recommended a final dividend of ₹10 per equity share (200 per cent) of face value ₹5 for the financial year 2024-25. This final dividend is subject to approval by shareholders at the upcoming Annual General Meeting (AGM). Earlier in the year, on February 10, 2025, the Board had declared an interim dividend of ₹9 per equity share (180 per cent), which was paid on February 28, 2025. With the proposed final dividend, the total dividend for FY2024-25 amounts to ₹19 per equity share (380 per cent), translating to a total payout of ₹273.1 crore. The company has fixed Tuesday, August 19, 2025, as the record date to determine the eligibility of shareholders for the final dividend as well as for participation in the AGM. About Apollo Hospitals Apollo Hospitals was founded by Prathap Reddy in 1983 with the opening of its first hospital in Chennai. Today, it operates as the world's largest integrated healthcare platform, with over 70,000 beds across 73 hospitals, more than 6,600 pharmacies, over 260 clinics, 2,200 diagnostic centres, and more than 800 telemedicine centres. Apollo is a leading cardiac care provider, having completed over 300,000 angioplasties and 200,000 surgeries. The group continues to invest in advanced technologies and treatment protocols to improve healthcare delivery. It employs around 120,000 people across its operations.
